Steven J. Siegel - Publications

University of Pennsylvania, Philadelphia, PA, United States 
Schizophrenia, Drug-delivery

151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Ferri SL, Pallathra AA, Kim H, Dow HC, Raje P, McMullen M, Bilker WB, Siegel SJ, Abel T, Brodkin ES. Sociability development in mice with cell-specific deletion of the NMDA receptor NR1 subunit gene. Genes, Brain, and Behavior. e12624. PMID 31721416 DOI: 10.1111/Gbb.12624  0.72
2019 Zhang RV, Featherstone RE, Melynchenko O, Gifford R, Weger R, Liang Y, Siegel SJ. High-beta/low-gamma frequency activity reflects top-down predictive coding during a spatial working memory test. Experimental Brain Research. PMID 31093716 DOI: 10.1007/S00221-019-05558-3  0.76
2019 Ward KR, Featherstone RE, Naschek MJ, Melnychenko O, Banerjee A, Yi J, Gifford RL, Borgmann-Winter KE, Salter MW, Hahn CG, Siegel SJ. Src deficient mice demonstrate behavioral and electrophysiological alterations relevant to psychiatric and developmental disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30826459 DOI: 10.1016/J.Pnpbp.2019.02.017  0.52
2018 Port RG, Berman J, Liu S, Featherstone RE, Roberts TPL, Siegel SJ. Parvalbumin cell ablation of NMDA-R1 leads to altered phase, but not amplitude, of gamma-band cross frequency coupling. Brain Connectivity. PMID 30588822 DOI: 10.1089/Brain.2018.0639  0.52
2018 Wang HY, MacDonald ML, Borgmann-Winter KE, Banerjee A, Sleiman P, Tom A, Khan A, Lee KC, Roussos P, Siegel SJ, Hemby SE, Bilker WB, Gur RE, Hahn CG. mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia. Molecular Psychiatry. PMID 30214040 DOI: 10.1038/S41380-018-0234-Y  0.4
2018 Forrest AD, Bang J, Featherstone RE, Bloom JH, Luminais MS, Zhang RV, Gajewski CR, McMullen MF, Liang Y, Siegel SJ. Pyramidal cell-selective GluN1 knockout causes impairments in salience attribution and related EEG activity. Experimental Brain Research. PMID 29350251 DOI: 10.1007/S00221-017-5152-8  0.76
2017 Grissom NM, McKee SE, Schoch H, Bowman N, Havekes R, O'Brien WT, Mahrt E, Siegel S, Commons K, Portfors C, Nickl-Jockschat T, Reyes TM, Abel T. Male-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders. Molecular Psychiatry. PMID 29038598 DOI: 10.1038/Mp.2017.184  0.72
2017 Port RG, Gajewski C, Krizman E, Dow HC, Hirano S, Brodkin ES, Carlson GC, Robinson MB, Roberts TPL, Siegel SJ. Protocadherin 10 alters γ oscillations, amino acid levels, and their coupling; baclofen partially restores these oscillatory deficits. Neurobiology of Disease. PMID 28844789 DOI: 10.1016/J.Nbd.2017.08.013  0.48
2017 Featherstone RE, Melnychenko O, Siegel SJ. Mismatch negativity in preclinical models of schizophrenia. Schizophrenia Research. PMID 28768598 DOI: 10.1016/J.Schres.2017.07.039  0.52
2017 Mihara T, Mensah-Brown K, Sobota R, Lin R, Featherstone R, Siegel SJ. Amygdala activity associated with social choice in mice. Behavioural Brain Research. PMID 28438555 DOI: 10.1016/J.Bbr.2017.04.040  0.76
2016 Choi CH, Schoenfeld BP, Bell AJ, Hinchey J, Rosenfelt C, Gertner MJ, Campbell SR, Emerson D, Hinchey P, Kollaros M, Ferrick NJ, Chambers DB, Langer S, Sust S, Malik A, ... ... Siegel SJ, et al. Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models. Frontiers in Behavioral Neuroscience. 10: 136. PMID 27445731 DOI: 10.3389/Fnbeh.2016.00136  1
2016 White RS, Bhattacharya AK, Chen Y, Byrd M, McMullen MF, Siegel SJ, Carlson GC, Kim SF. Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1. Molecular Brain. 9: 38. PMID 27080392 DOI: 10.1186/S13041-016-0220-8  1
2016 Carlson GC, Lin RE, Chen Y, Brookshire BR, White RS, Lucki I, Siegel SJ, Kim SF. Dexras1 a unique ras-GTPase interacts with NMDA receptor activity and provides a novel dissociation between anxiety, working memory and sensory gating. Neuroscience. PMID 26946266 DOI: 10.1016/j.neuroscience.2016.02.063  0.48
2015 Kogan JH, Gross AK, Featherstone RE, Shin R, Chen Q, Heusner CL, Adachi M, Lin A, Walton NM, Miyoshi S, Miyake S, Tajinda K, Ito H, Siegel SJ, Matsumoto M. Mouse Model of Chromosome 15q13.3 Microdeletion Syndrome Demonstrates Features Related to Autism Spectrum Disorder. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 16282-16294. PMID 26658876 DOI: 10.1523/Jneurosci.3967-14.2015  0.52
2015 White RS, Siegel SJ. Cellular and circuit models of increased resting-state network gamma activity in schizophrenia. Neuroscience. PMID 26577758 DOI: 10.1016/j.neuroscience.2015.11.011  1
2015 Featherstone RE, Siegel SJ. The Role of Nicotine in Schizophrenia. International Review of Neurobiology. 124: 23-78. PMID 26472525 DOI: 10.1016/Bs.Irn.2015.07.002  1
2015 Dodman K, Featherstone RE, Bang J, Liang Y, Siegel SJ. Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice. Drug and Alcohol Dependence. 156: 14-20. PMID 26442907 DOI: 10.1016/J.Drugalcdep.2015.07.1198  1
2015 Nagy LR, Featherstone RE, Hahn CG, Siegel SJ. Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice. Translational Psychiatry. 5: e635. PMID 26371763 DOI: 10.1038/Tp.2015.111  0.52
2015 Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ. Oxytocin reduces amygdala activity, increases social interactions, and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behavioral Neuroscience. 129: 389-98. PMID 26214213 DOI: 10.1037/Bne0000074  1
2015 Featherstone RE, McMullen MF, Ward KR, Bang J, Xiao J, Siegel SJ. EEG biomarkers of target engagement, therapeutic effect, and disease process. Annals of the New York Academy of Sciences. 1344: 12-26. PMID 25823856 DOI: 10.1111/Nyas.12745  1
2015 Port RG, Anwar AR, Ku M, Carlson GC, Siegel SJ, Roberts TP. Prospective MEG biomarkers in ASD: pre-clinical evidence and clinical promise of electrophysiological signatures. The Yale Journal of Biology and Medicine. 88: 25-36. PMID 25745372  1
2015 Choi CH, Schoenfeld BP, Weisz ED, Bell AJ, Chambers DB, Hinchey J, Choi RJ, Hinchey P, Kollaros M, Gertner MJ, Ferrick NJ, Terlizzi AM, Yohn N, Koenigsberg E, Liebelt DA, ... ... Siegel SJ, et al. PDE-4 inhibition rescues aberrant synaptic plasticity in Drosophila and mouse models of fragile X syndrome. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 396-408. PMID 25568131 DOI: 10.1523/Jneurosci.1356-12.2015  1
2015 Tatard-Leitman VM, Jutzeler CR, Suh J, Saunders JA, Billingslea EN, Morita S, White R, Featherstone RE, Ray R, Ortinski PI, Banerjee A, Gandal MJ, Lin R, Alexandrescu A, Liang Y, ... ... Siegel SJ, et al. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biological Psychiatry. 77: 556-68. PMID 25156700 DOI: 10.1016/J.Biopsych.2014.06.026  1
2015 Port RG, Anwar AR, Ku M, Carlson GC, Siegel SJ, Roberts TPL. Prospective MEG biomarkers in ASD: Pre-Clinical evidence and clinical promise of electrophysiological signatures Yale Journal of Biology and Medicine. 88: 25-36.  1
2014 Port RG, Gandal MJ, Roberts TP, Siegel SJ, Carlson GC. Convergence of circuit dysfunction in ASD: a common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology. Frontiers in Cellular Neuroscience. 8: 414. PMID 25538564 DOI: 10.3389/Fncel.2014.00414  1
2014 Mihara T, Siegel SJ. [Ketamine alters socially-evoked activity in the amygdala]. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica. 144: 272-6. PMID 25492362 DOI: DN/JST.JSTAGE/fpj/144.272  1
2014 Featherstone RE, Shin R, Kogan JH, Liang Y, Matsumoto M, Siegel SJ. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population. Neurobiology of Disease. 73: 289-295. PMID 25461194 DOI: 10.1016/J.Nbd.2014.10.010  1
2014 Banerjee A, Wang HY, Borgmann-Winter KE, MacDonald ML, Kaprielian H, Stucky A, Kvasic J, Egbujo C, Ray R, Talbot K, Hemby SE, Siegel SJ, Arnold SE, Sleiman P, Chang X, et al. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia. Molecular Psychiatry. PMID 25330739 DOI: 10.1038/mp.2014.115  0.4
2014 Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host & Microbe. 16: 55-67. PMID 25011108 DOI: 10.1016/J.Chom.2014.06.005  1
2014 Goffin D, Brodkin ES, Blendy JA, Siegel SJ, Zhou Z. Cellular origins of auditory event-related potential deficits in Rett syndrome. Nature Neuroscience. 17: 804-6. PMID 24777420 DOI: 10.1038/Nn.3710  1
2014 Billingslea EN, Tatard-Leitman VM, Anguiano J, Jutzeler CR, Suh J, Saunders JA, Morita S, Featherstone RE, Ortinski PI, Gandal MJ, Lin R, Liang Y, Gur RE, Carlson GC, Hahn CG, ... Siegel SJ, et al. Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1603-13. PMID 24525709 DOI: 10.1038/Npp.2014.7  1
2014 Featherstone RE, Nagy LR, Hahn CG, Siegel SJ. Juvenile exposure to ketamine causes delayed emergence of EEG abnormalities during adulthood in mice. Drug and Alcohol Dependence. 134: 123-7. PMID 24210161 DOI: 10.1016/J.Drugalcdep.2013.09.017  1
2013 Lin RE, Ambler L, Billingslea EN, Suh J, Batheja S, Tatard-Leitman V, Featherstone RE, Siegel SJ. Electroencephalographic and early communicative abnormalities in Brattleboro rats. Physiological Reports. 1: e00100. PMID 24303172 DOI: 10.1002/Phy2.100  0.52
2013 Siegel SJ. Capacity, confidentiality and consequences: balancing responsible medical care with mental health law. Current Psychiatry Reports. 15: 380. PMID 23881711 DOI: 10.1007/s11920-013-0380-5  1
2013 Siegel SJ, Talpos JC, Geyer MA. Animal models and measures of perceptual processing in schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2092-8. PMID 23867801 DOI: 10.1016/j.neubiorev.2013.06.016  1
2013 Schoenfeld BP, Choi RJ, Choi CH, Terlizzi AM, Hinchey P, Kollaros M, Ferrick NJ, Koenigsberg E, Ferreiro D, Leibelt DA, Siegel SJ, Bell AJ, McDonald TV, Jongens TA, McBride SM. The Drosophila DmGluRA is required for social interaction and memory. Frontiers in Pharmacology. 4: 64. PMID 23720628 DOI: 10.3389/Fphar.2013.00064  1
2013 Moessnang C, Pauly K, Kellermann T, Krämer J, Finkelmeyer A, Hummel T, Siegel SJ, Schneider F, Habel U. The scent of salience--is there olfactory-trigeminal conditioning in humans? Neuroimage. 77: 93-104. PMID 23558094 DOI: 10.1016/J.Neuroimage.2013.03.049  1
2013 Saunders JA, Tatard-Leitman VM, Suh J, Billingslea EN, Roberts TP, Siegel SJ. Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes. Autism Research : Official Journal of the International Society For Autism Research. 6: 69-77. PMID 23441094 DOI: 10.1002/Aur.1264  1
2013 Featherstone RE, M Tatard-Leitman V, Suh JD, Lin R, Lucki I, Siegel SJ. Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression. Psychopharmacology. 227: 639-49. PMID 23392353 DOI: 10.1007/S00213-013-2997-9  1
2013 De Rojas JO, Saunders JA, Luminais C, Hamilton RH, Siegel SJ. Electroencephalographic changes following direct current deep brain stimulation of auditory cortex: a new model for investigating neuromodulation. Neurosurgery. 72: 267-75; discussion 2. PMID 23149971 DOI: 10.1227/Neu.0B013E31827B93C0  1
2013 Uchil PD, Hinz A, Siegel S, Coenen-Stass A, Pertel T, Luban J, Mothes W. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. Journal of Virology. 87: 257-72. PMID 23077300 DOI: 10.1128/Jvi.01804-12  1
2013 Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. Brain activity and emotional processing in smokers treated with varenicline. Addiction Biology. 18: 732-8. PMID 21507156 DOI: 10.1111/J.1369-1600.2011.00324.X  1
2012 Wang IT, Allen M, Goffin D, Zhu X, Fairless AH, Brodkin ES, Siegel SJ, Marsh ED, Blendy JA, Zhou Z. Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. Proceedings of the National Academy of Sciences of the United States of America. 109: 21516-21. PMID 23236174 DOI: 10.1073/Pnas.1216988110  1
2012 Rabin CR, Siegel SJ. Delivery systems and dosing for antipsychotics. Handbook of Experimental Pharmacology. 267-98. PMID 23129336 DOI: 10.1007/978-3-642-25761-2_11  1
2012 Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. Plos One. 7: e39775. PMID 22911690 DOI: 10.1371/Journal.Pone.0039775  1
2012 Moessnang C, Habel U, Schneider F, Siegel SJ. The electrophysiological signature of motivational salience in mice and implications for schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2846-54. PMID 22910459 DOI: 10.1038/npp.2012.156  1
2012 Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, Thieu T, Anderson R, Pierce RC, Jonak G, Gur RE, Carlson G, Siegel SJ. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Translational Psychiatry. 2: e142. PMID 22806213 DOI: 10.1038/tp.2012.69  1
2012 Saunders JA, Gandal MJ, Roberts TP, Siegel SJ. NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders. Behavioural Brain Research. 234: 233-7. PMID 22771812 DOI: 10.1016/J.Bbr.2012.06.032  1
2012 Gandal MJ, Anderson RL, Billingslea EN, Carlson GC, Roberts TP, Siegel SJ. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? Genes, Brain, and Behavior. 11: 740-50. PMID 22726567 DOI: 10.1111/j.1601-183X.2012.00816.x  1
2012 Featherstone RE, Liang Y, Saunders JA, Tatard-Leitman VM, Ehrlichman RS, Siegel SJ. Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice. Neurobiology of Disease. 47: 338-46. PMID 22627142 DOI: 10.1016/J.Nbd.2012.05.003  1
2012 Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behavioral Neuroscience. 126: 332-43. PMID 22309446 DOI: 10.1037/A0027047  1
2012 Liao W, Gandal MJ, Ehrlichman RS, Siegel SJ, Carlson GC. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Neurobiology of Disease. 46: 88-92. PMID 22249109 DOI: 10.1016/J.Nbd.2011.12.048  1
2012 Saunders JA, Gandal MJ, Siegel SJ. NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia. Neurobiology of Disease. 46: 93-100. PMID 22245663 DOI: 10.1016/J.Nbd.2011.12.049  1
2012 Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, Mercado-Berton A, Ong C, Cohen S, Hu L, Blendy JA, Carlson GC, Siegel SJ, Greenberg ME, Zhou Z. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nature Neuroscience. 15: 274-83. PMID 22119903 DOI: 10.1038/Nn.2997  1
2012 Siegel S, Sanacora G. The roles of glutamate receptors across major neurological and psychiatric disorders. Pharmacology, Biochemistry, and Behavior. 100: 653-5. PMID 22108650 DOI: 10.1016/j.pbb.2011.11.002  1
2012 Gandal MJ, Edgar JC, Klook K, Siegel SJ. Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology. 62: 1504-18. PMID 21349276 DOI: 10.1016/j.neuropharm.2011.02.007  1
2012 Roberts TPL, Gandal M, Siegel SJ, Vianney–Rodrigues P, Welsh JP. Autism spectrum disorders Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders. 273-302. DOI: 10.1017/CBO9780511980053.017  1
2011 Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers. 3: 1377-1397. PMID 22577513 DOI: 10.3390/polym3031377  1
2011 Mehta MV, Gandal MJ, Siegel SJ. mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. Plos One. 6: e26077. PMID 22016815 DOI: 10.1371/journal.pone.0026077  1
2011 Carlson GC, Talbot K, Halene TB, Gandal MJ, Kazi HA, Schlosser L, Phung QH, Gur RE, Arnold SE, Siegel SJ. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 108: E962-70. PMID 21969553 DOI: 10.1073/Pnas.1109625108  1
2011 Siegel SJ. What can we expect from long-acting formulations for schizophrenia? Current Psychiatry Reports. 13: 243-4. PMID 21584690 DOI: 10.1007/s11920-011-0206-2  1
2011 Berger AK, Green T, Siegel SJ, Nestler EJ, Hammer RP. cAMP response element binding protein phosphorylation in nucleus accumbens underlies sustained recovery of sensorimotor gating following repeated D₂-like receptor agonist treatment in rats. Biological Psychiatry. 69: 288-94. PMID 21035786 DOI: 10.1016/J.Biopsych.2010.08.032  1
2010 Rabin CR, Siegel SJ. Antipsychotic dosing and drug delivery. Current Topics in Behavioral Neurosciences. 4: 141-77. PMID 21312400 DOI: 10.1007/7854_2010_46  1
2010 Gandal MJ, Edgar JC, Ehrlichman RS, Mehta M, Roberts TP, Siegel SJ. Validating γ oscillations and delayed auditory responses as translational biomarkers of autism. Biological Psychiatry. 68: 1100-6. PMID 21130222 DOI: 10.1016/J.Biopsych.2010.09.031  1
2010 Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ. Mouse behavioral endophenotypes for schizophrenia. Brain Research Bulletin. 83: 147-61. PMID 20433908 DOI: 10.1016/J.Brainresbull.2010.04.008  1
2010 Siegel SJ. Resurgence of long-acting antipsychotic formulations. Current Psychiatry Reports. 12: 276-8. PMID 20424976 DOI: 10.1007/s11920-010-0121-y  1
2010 Amann LC, Gandal MJ, Lin R, Liang Y, Siegel SJ. In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharmaceutical Research. 27: 1730-7. PMID 20422263 DOI: 10.1007/s11095-010-0152-4  1
2010 Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 589-97. PMID 20395358 DOI: 10.1093/Ntr/Ntq049  1
2010 Dankert ME, Brensinger CM, Ralph LN, Seward DA, Bilker WB, Siegel SJ. Psychiatric health care provider attitudes towards implantable medication. Psychiatry Research. 177: 167-71. PMID 20378184 DOI: 10.1016/J.Psychres.2008.12.012  1
2010 Li X, Du Y, Siegel S, Ferro-Novick S, Novick P. Activation of the mitogen-activated protein kinase, Slt2p, at bud tips blocks a late stage of endoplasmic reticulum inheritance in Saccharomyces cerevisiae. Molecular Biology of the Cell. 21: 1772-82. PMID 20357006 DOI: 10.1091/Mbc.E09-06-0532  1
2010 Wang CK, Wang WY, Meyer RF, Liang Y, Winey KI, Siegel SJ. A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing process. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 93: 562-72. PMID 20225251 DOI: 10.1002/Jbm.B.31617  1
2010 Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry. 67: 715-21. PMID 20207347 DOI: 10.1016/J.Biopsych.2010.01.016  1
2010 Satterthwaite TD, Wolf DH, Loughead J, Ruparel K, Valdez JN, Siegel SJ, Kohler CG, Gur RE, Gur RC. Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia. The American Journal of Psychiatry. 167: 418-26. PMID 20194482 DOI: 10.1176/Appi.Ajp.2009.09060808  1
2010 Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. Working memory deficits predict short-term smoking resumption following brief abstinence Drug and Alcohol Dependence. 106: 61-64. PMID 19733449 DOI: 10.1016/J.Drugalcdep.2009.07.020  1
2010 Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal MJ, Finkel LH, Siegel SJ. Ketamine modulates theta and gamma oscillations. Journal of Cognitive Neuroscience. 22: 1452-64. PMID 19583475 DOI: 10.1162/Jocn.2009.21305  1
2009 Ehrlichman RS, Luminais SN, White SL, Rudnick ND, Ma N, Dow HC, Kreibich AS, Abel T, Brodkin ES, Hahn CG, Siegel SJ. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Research. 1294: 116-27. PMID 19643092 DOI: 10.1016/J.Brainres.2009.07.065  1
2009 Halene TB, Talmud J, Jonak GJ, Schneider F, Siegel SJ. Predator odor modulates auditory event-related potentials in mice. Neuroreport. 20: 1260-4. PMID 19625986 DOI: 10.1097/WNR.0b013e3283300cde  1
2009 Bodarky CL, Halene TB, Ehrlichman RS, Banerjee A, Ray R, Hahn CG, Jonak G, Siegel SJ. Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice. The Journal of Pharmacology and Experimental Therapeutics. 331: 308-18. PMID 19602553 DOI: 10.1124/Jpet.109.150938  1
2009 Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes, Brain, and Behavior. 8: 661-75. PMID 19563516 DOI: 10.1111/J.1601-183X.2009.00504.X  1
2009 Amann LC, Halene TB, Ehrlichman RS, Luminais SN, Ma N, Abel T, Siegel SJ. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Neurobiology of Disease. 35: 311-7. PMID 19467327 DOI: 10.1016/J.Nbd.2009.05.012  1
2009 Pierce M, Marbury T, O'Neill C, Siegel S, Du W, Sebree T. Zelrixtm: A novel transdermal formulation of sumatriptan Headache. 49: 817-825. PMID 19438727 DOI: 10.1111/J.1526-4610.2009.01437.X  1
2009 Ehrlichman RS, Gandal MJ, Maxwell CR, Lazarewicz MT, Finkel LH, Contreras D, Turetsky BI, Siegel SJ. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience. 158: 705-12. PMID 19015010 DOI: 10.1016/J.Neuroscience.2008.10.031  1
2009 Turetsky BI, Bilker WB, Siegel SJ, Kohler CG, Gur RE. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Research. 165: 27-37. PMID 18990453 DOI: 10.1016/J.Psychres.2008.04.013  1
2009 Rudnick ND, Koehler C, Picciotto MR, Siegel SJ. Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials. Psychopharmacology. 202: 745-51. PMID 18931833 DOI: 10.1007/s00213-008-1358-6  1
2009 Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C. Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry. 65: 144-9. PMID 18842256 DOI: 10.1016/J.Biopsych.2008.08.028  1
2008 Gandal MJ, Ehrlichman RS, Rudnick ND, Siegel SJ. A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience. 157: 95-104. PMID 18835334 DOI: 10.1016/J.Neuroscience.2008.08.060  1
2008 Amann LC, Phillips JM, Halene TB, Siegel SJ. Male and female mice differ for baseline and nicotine-induced event related potentials. Behavioral Neuroscience. 122: 982-90. PMID 18823155 DOI: 10.1037/a0012995  1
2008 Dankert ME, Brensinger CM, Metzger KL, Li C, Koleva SG, Mesén A, Laprade B, Wiguna T, Han C, Farooq S, Severus WE, Gayares JG, Langosch JM, Lallart X, Tateno M, ... ... Siegel SJ, et al. Attitudes of patients and family members towards implantable psychiatric medication. Schizophrenia Research. 105: 279-86. PMID 18571376 DOI: 10.1016/J.Schres.2008.05.008  1
2008 Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. A placebo-controlled trial of modafinil for nicotine dependence. Drug and Alcohol Dependence. 98: 86-93. PMID 18541389 DOI: 10.1016/J.Drugalcdep.2008.04.008  1
2008 Halene TB, Siegel SJ. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. The Journal of Pharmacology and Experimental Therapeutics. 326: 230-9. PMID 18420599 DOI: 10.1124/jpet.108.138586  1
2008 Ehrlichman RS, Maxwell CR, Majumdar S, Siegel SJ. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice. Journal of Cognitive Neuroscience. 20: 1403-14. PMID 18303985 DOI: 10.1162/Jocn.2008.20097  1
2008 Kelly MP, Cheung YF, Favilla C, Siegel SJ, Kanes SJ, Houslay MD, Abel T. Constitutive activation of the G-protein subunit Galphas within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 75-83. PMID 18230676 DOI: 10.1101/Lm.723708  1
2008 Ragland JD, Moelter ST, Bhati MT, Valdez JN, Kohler CG, Siegel SJ, Gur RC, Gur RE. Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia. Schizophrenia Research. 99: 312-23. PMID 18155880 DOI: 10.1016/J.Schres.2007.11.017  1
2008 Majewski-Tiedeken CR, Rabin CR, Siegel SJ. Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains. Drug and Alcohol Dependence. 92: 217-27. PMID 17920787 DOI: 10.1016/j.drugalcdep.2007.08.009  1
2008 Rabin C, Liang Y, Ehrlichman RS, Budhian A, Metzger KL, Majewski-Tiedeken C, Winey KI, Siegel SJ. In vitro and in vivo demonstration of risperidone implants in mice. Schizophrenia Research. 98: 66-78. PMID 17765477 DOI: 10.1016/J.Schres.2007.08.003  1
2008 Budhian A, Siegel SJ, Winey KI. Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles. International Journal of Pharmaceutics. 346: 151-9. PMID 17681683 DOI: 10.1016/J.Ijpharm.2007.06.011  1
2008 Rosenberg RT, Siegel SJ, Dan N. Release of highly hydrophilic drugs from poly(ε-caprolactone) matrices Journal of Applied Polymer Science. 107: 3149-3156. DOI: 10.1002/App.27511  1
2007 Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: S583-98. PMID 18067034 DOI: 10.1080/14622200701691755  1
2007 Halene TB, Siegel SJ. PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia? Drug Discovery Today. 12: 870-8. PMID 17933689 DOI: 10.1016/j.drudis.2007.07.023  1
2007 Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA. Translational research in medication development for nicotine dependence. Nature Reviews. Drug Discovery. 6: 746-62. PMID 17690709 DOI: 10.1038/Nrd2361  1
2007 Siegel SJ, O'Neill C, Dubé LM, Kaldeway P, Morris R, Jackson D, Sebree T. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Pharmaceutical Research. 24: 1919-26. PMID 17577644 DOI: 10.1007/s11095-007-9317-1  1
2007 Hans ML, Maxwell C, Ehrlichman RS, Metzger K, Liang Y, Siegel SJ, Lowman AM. Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 83: 422-30. PMID 17415770 DOI: 10.1002/Jbm.B.30812  1
2007 Kane JM, Leucht S, Marder SR, Robinson DG, Siegel S. New developments in the treatment of schizophrenia Journal of Clinical Psychiatry. 68: 463-478. PMID 17388719  1
2007 Gur RE, Turetsky BI, Loughead J, Snyder W, Kohler C, Elliott M, Pratiwadi R, Ragland JD, Bilker WB, Siegel SJ, Kanes SJ, Arnold SE, Gur RC. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. The American Journal of Psychiatry. 164: 442-9. PMID 17329469 DOI: 10.1176/Ajp.2007.164.3.442  1
2007 Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. International Journal of Pharmaceutics. 336: 367-75. PMID 17207944 DOI: 10.1016/J.Ijpharm.2006.11.061  1
2007 Phillips JM, Ehrlichman RS, Siegel SJ. Mecamylamine blocks nicotine-induced enhancement of the P20 auditory event-related potential and evoked gamma. Neuroscience. 144: 1314-23. PMID 17184927 DOI: 10.1016/J.Neuroscience.2006.11.003  1
2007 Metzger KL, Shoemaker JM, Kahn JB, Maxwell CR, Liang Y, Tokarczyk J, Kanes SJ, Hans M, Lowman AM, Dan N, Winey KI, Swerdlow NR, Siegel SJ. Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits. Psychopharmacology. 190: 201-11. PMID 17119931 DOI: 10.1007/S00213-006-0616-8  1
2007 Kanes SJ, Tokarczyk J, Siegel SJ, Bilker W, Abel T, Kelly MP. Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. Neuroscience. 144: 239-46. PMID 17081698 DOI: 10.1016/J.Neuroscience.2006.09.026  1
2007 Kelly MP, Isiegas C, Cheung YF, Tokarczyk J, Yang X, Esposito MF, Rapoport DA, Fabian SA, Siegel SJ, Wand G, Houslay MD, Kanes SJ, Abel T. Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 577-88. PMID 16738544 DOI: 10.1038/Sj.Npp.1301099  1
2007 Metzger KL, Maxwell CR, Liang Y, Siegel SJ. Effects of nicotine vary across two auditory evoked potentials in the mouse. Biological Psychiatry. 61: 23-30. PMID 16497274 DOI: 10.1016/J.Biopsych.2005.12.011  1
2006 Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR, Gur RC, Kohler CG, Kanes SJ, Siegel SJ, Turetsky BI. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. Journal of Clinical and Experimental Neuropsychology. 28: 1444-61. PMID 17050269 DOI: 10.1080/13803390500434409  1
2006 Irani F, Platek SM, Panyavin IS, Calkins ME, Kohler C, Siegel SJ, Schachter M, Gur RE, Gur RC. Self-face recognition and theory of mind in patients with schizophrenia and first-degree relatives. Schizophrenia Research. 88: 151-60. PMID 16979876 DOI: 10.1016/J.Schres.2006.07.016  1
2006 Siegel S. Extended-release intramuscular naltrexone: A viewpoint by Steven Siegel Drugs. 66: 1752. PMID 16978040 DOI: 10.2165/00003495-200666130-00007  1
2006 Roalf DR, Turetsky BI, Owzar K, Balderston CC, Johnson SC, Brensinger CM, Gur RE, Siegel SJ, Moberg PJ. Unirhinal olfactory function in schizophrenia patients and first-degree relatives. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 389-96. PMID 16963589 DOI: 10.1176/jnp.2006.18.3.389  1
2006 Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N. Effect of drug type on the degradation rate of PLGA matrices. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 64: 287-93. PMID 16949804 DOI: 10.1016/J.Ejpb.2006.06.009  1
2006 Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine. 12: 824-8. PMID 16767099 DOI: 10.1038/Nm1418  1
2006 Maxwell CR, Liang Y, Kelly MP, Kanes SJ, Abel T, Siegel SJ. Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients. Neuroscience. 141: 1257-64. PMID 16750890 DOI: 10.1016/J.Neuroscience.2006.04.028  1
2006 Siegel SJ, Irani F, Brensinger CM, Kohler CG, Bilker WB, Ragland JD, Kanes SJ, Gur RC, Gur RE. Prognostic variables at intake and long-term level of function in schizophrenia. The American Journal of Psychiatry. 163: 433-41. PMID 16513864 DOI: 10.1176/Appi.Ajp.163.3.433  1
2006 Gur RE, Kohler CG, Ragland JD, Siegel SJ, Lesko K, Bilker WB, Gur RC. Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophrenia Bulletin. 32: 279-87. PMID 16452608 DOI: 10.1093/Schbul/Sbj041  1
2006 Maxwell CR, Ehrlichman RS, Liang Y, Trief D, Kanes SJ, Karp J, Siegel SJ. Ketamine produces lasting disruptions in encoding of sensory stimuli. The Journal of Pharmacology and Experimental Therapeutics. 316: 315-24. PMID 16192313 DOI: 10.1124/Jpet.105.091199  1
2006 Maxwell CR, Ehrlichman RS, Liang Y, Gettes DR, Evans DL, Kanes SJ, Abel T, Karp J, Siegel SJ. Corticosterone modulates auditory gating in mouse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 897-903. PMID 16123740 DOI: 10.1038/Sj.Npp.1300879  1
2006 Irani F, Siegel SJ. Predicting outcome in Schizophrenia Psychiatric Times. 23: 69-70.  1
2005 Budhian A, Siegel SJ, Winey KI. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. Journal of Microencapsulation. 22: 773-85. PMID 16421087 DOI: 10.1080/02652040500273753  1
2005 Ragland JD, Gur RC, Valdez JN, Loughead J, Elliott M, Kohler C, Kanes S, Siegel SJ, Moelter ST, Gur RE. Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. The American Journal of Psychiatry. 162: 1840-8. PMID 16199830 DOI: 10.1176/Appi.Ajp.162.10.1840  1
2005 Davis JA, James JR, Siegel SJ, Gould TJ. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 8708-13. PMID 16177040 DOI: 10.1523/Jneurosci.2853-05.2005  1
2005 Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience. 133: 729-38. PMID 15908134 DOI: 10.1016/J.Neuroscience.2005.03.027  1
2005 Frankel WN, Beyer B, Maxwell CR, Pretel S, Letts VA, Siegel SJ. Development of a new genetic model for absence epilepsy: spike-wave seizures in C3H/He and backcross mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 3452-8. PMID 15800200 DOI: 10.1523/Jneurosci.0231-05.2005  1
2004 Maxwell CR, Kanes SJ, Abel T, Siegel SJ. Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. Neuroscience. 129: 101-7. PMID 15489033 DOI: 10.1016/J.Neuroscience.2004.07.038  1
2004 Irani F, Dankert M, Siegel SJ. Patient and family attitudes toward schizophrenia treatment. Current Psychiatry Reports. 6: 283-8. PMID 15260944 DOI: 10.1007/S11920-004-0078-9  1
2004 Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, Siegel SJ. The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochemical Research. 29: 1179-88. PMID 15176475 DOI: 10.1023/B:Nere.0000023605.68408.Fb  1
2004 Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. The Journal of Clinical Investigation. 113: 1353-63. PMID 15124027 DOI: 10.1172/Jci20425  1
2004 Gur RE, Kohler C, Turetsky BI, Siegel SJ, Kanes SJ, Bilker WB, Brennan AR, Gur RC. A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biological Psychiatry. 55: 512-7. PMID 15023579 DOI: 10.1016/J.Biopsych.2003.10.009  1
2004 Gelber EI, Kohler CG, Bilker WB, Gur RC, Brensinger C, Siegel SJ, Gur RE. Symptom and demographic profiles in first-episode schizophrenia. Schizophrenia Research. 67: 185-94. PMID 14984877 DOI: 10.1016/S0920-9964(03)00083-5  1
2004 Irani F, Dankert M, Brensinger C, Bilker WB, Nair SR, Kohler CG, Kanes SJ, Turetsky BI, Moberg PJ, Ragland JD, Gur RC, Gur RE, Siegel SJ. Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 960-8. PMID 14970826 DOI: 10.1038/Sj.Npp.1300385  1
2004 Maxwell CR, Liang Y, Weightman BD, Kanes SJ, Abel T, Gur RE, Turetsky BI, Bilker WB, Lenox RH, Siegel SJ. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 739-46. PMID 14735128 DOI: 10.1038/Sj.Npp.1300376  1
2004 Gould TJ, Bizily SP, Tokarczyk J, Kelly MP, Siegel SJ, Kanes SJ, Abel T. Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 494-501. PMID 14694347 DOI: 10.1038/Sj.Npp.1300309  1
2003 Ragland JD, Moelter ST, McGrath C, Hill SK, Gur RE, Bilker WB, Siegel SJ, Gur RC. Levels-of-processing effect on word recognition in schizophrenia. Biological Psychiatry. 54: 1154-61. PMID 14643082 DOI: 10.1016/S0006-3223(03)00235-X  1
2003 Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J, Bilker WB, Turetsky BI, Gur RE, Siegel SJ. Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains. Brain Research. 992: 85-95. PMID 14604776 DOI: 10.1016/J.Brainres.2003.08.035  1
2003 Kohler CG, Turner TH, Bilker WB, Brensinger CM, Siegel SJ, Kanes SJ, Gur RE, Gur RC. Facial emotion recognition in schizophrenia: intensity effects and error pattern. The American Journal of Psychiatry. 160: 1768-74. PMID 14514489 DOI: 10.1176/Appi.Ajp.160.10.1768  1
2003 Gur RE, Kohler C, Ragland JD, Siegel SJ, Bilker WB, Loughead J, Phend N, Gur RC. Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2029-36. PMID 12902996 DOI: 10.1038/Sj.Npp.1300275  1
2003 Bilker WB, Brensinger C, Kurtz MM, Kohler C, Gur RC, Siegel SJ, Gur RE. Development of an abbreviated schizophrenia quality of life scale using a new method. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 773-7. PMID 12655324 DOI: 10.1038/Sj.Npp.1300093  1
2003 Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB, Kanes SJ, Turetsky BI. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 675-82. PMID 12655312 DOI: 10.1038/Sj.Npp.1300087  1
2002 Siegel SJ, Winey KI, Gur RE, Lenox RH, Bilker WB, Ikeda D, Gandhi N, Zhang WX. Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 817-23. PMID 12007752 DOI: 10.1016/S0893-133X(01)00426-2  1
2001 Gur RC, Ragland JD, Moberg PJ, Bilker WB, Kohler C, Siegel SJ, Gur RE. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 777-88. PMID 11682261 DOI: 10.1016/S0893-133X(01)00279-2  1
2001 Gur RC, Ragland JD, Moberg PJ, Turner TH, Bilker WB, Kohler C, Siegel SJ, Gur RE. Computerized neurocognitive scanning: I. Methodology and validation in healthy people. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 766-76. PMID 11682260 DOI: 10.1016/S0893-133X(01)00278-0  1
1996 Gazzaley AH, Siegel SJ, Kordower JH, Mufson EJ, Morrison JH. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proceedings of the National Academy of Sciences of the United States of America. 93: 3121-5. PMID 8610179 DOI: 10.1073/Pnas.93.7.3121  1
1996 Morrison JH, Siegel SJ, Gazzaley AH, Huntley GW. ■ REVIEW : Glutamate Receptors: Emerging Links Between Subunit Proteins and Specific Excitatory Circuits in Primate Hippocampus and Neocortex: The Neuroscientist. 2: 272-283. DOI: 10.1177/107385849600200513  0.96
1996 Morrison JH, Siegel SJ, Gazzaley AH, Huntley GW. Glutamate receptors: Emerging links between subunit proteins and specific excitatory circuits in primate hippocampus and neocortex Neuroscientist. 2: 272-283.  1
1995 Siegel SJ, Janssen WG, Tullai JW, Rogers SW, Moran T, Heinemann SF, Morrison JH. Distribution of the excitatory amino acid receptor subunits GluR2(4) in monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 2707-19. PMID 7722624 DOI: 10.1523/Jneurosci.15-04-02707.1995  1
1994 Siegel SJ, Brose N, Janssen WG, Gasic GP, Jahn R, Heinemann SF, Morrison JH. Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 91: 564-8. PMID 8290563 DOI: 10.1073/Pnas.91.2.564  1
1993 Siegel SJ, Ginsberg SD, Hof PR, Foote SL, Young WG, Kraemer GW, McKinney WT, Morrison JH. Effects of social deprivation in prepubescent rhesus monkeys: immunohistochemical analysis of the neurofilament protein triplet in the hippocampal formation. Brain Research. 619: 299-305. PMID 8374785 DOI: 10.1016/0006-8993(93)91624-2  1
Show low-probability matches.